Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Uterine Cervical Neoplasms × Conization × Clear all

Status

Terminated 2 Recruiting 2 Unknown 1 Not yet recruiting 1 Enrolling by invitation 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1

Interventions

Cisplatin 8 Brachytherapy 5 Paclitaxel 4 Radiotherapy 3 Platinum 3 zimberelimab 2 pembrolizumab 2 nimotuzumab 2 envafolimab 2 Surveys and Questionnaires 2 Injections 2 Human Papillomavirus Recombinant Vaccine nonavalent 2 Drug Therapy 2 trilaciclib 1 toripalimab 1 tislelizumab 1 sintilimab 1 potassium oxonate 1 neratinib 1 lenvatinib 1 gimeracil 1 fludarabine 1 endostar protein 1 camrelizumab 1 bemarituzumab 1 Ultrasonography, Doppler 1 Topotecan 1 Telemedicine 1 Tegafur 1 Taxes 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06351228 2024-04-08

Eternity

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Not yet recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡